MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$557K
Free Cash flow
$890K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Revolving credit facility borrow...
Net income
Maturities of short-term investm...
Others
Negative Cash Flow Breakdown
Revolving credit facility repaym...
Inventories, net
Capital expenditures
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Net income
24,024
27,459
26,527
48,264
Non-cash impairment charges
-
-
-
5,328
Depreciation and amortization
12,448
12,891
12,830
45,605
Amortization of debt issuance costs
572
572
572
2,015
Deferred income taxes
3,659
3,838
2,171
-4,879
Foreign currency losses, net
-2,335
1,245
239
-600
Acquisition-related items
0
839
1,117
5,679
Stock-based compensation expense
411
434
339
717
Other
534
351
474
1,643
Accounts receivable, net
4,776
-2,333
-11,366
55,208
Inventories, net
19,328
47,032
26,181
44,294
Other current assets
603
-7,565
306
16,346
Other assets
-579
-271
105
-1,572
Accounts payable
-2,942
753
-4,627
45,555
Accrued expenses and other liabilities
361
11,025
-13,688
47,159
Net cash provided by operating activities
16,206
19,352
9,302
80,124
Purchases of short-term investments
13,000
11,522
12,504
14,000
Maturities of short-term investments
9,500
5,004
9,000
49,000
Capital expenditures
15,316
11,097
13,806
38,293
Business acquisition, net of cash acquired
-
-
-
286,529
Other, net
-2,010
-431
3,704
-1,134
Net cash used by investing activities
-16,806
-17,184
-21,014
-288,688
Revolving credit facility borrowings
73,000
62,000
86,000
532,000
Debt issuance costs
-
-
-
10,377
Revolving credit facility repayments
65,000
70,000
58,000
621,000
Proceeds from insurance premium financing and other short-term debt
-
-
-
7,530
Payments of long-term debt
4,063
4,062
4,063
325,014
Proceeds from long-term debt
-
-
-
650,000
Payments of insurance premium financing and other short-term debt
1,369
2,054
2,738
6,556
Dividends paid
4,868
4,864
4,864
19,449
Net cash (used) provided by financing activities
-2,300
-18,980
16,335
207,134
Effect of exchange rate changes on cash
2,343
-471
107
-1,144
Net decrease in cash and cash equivalents
-557
-17,283
4,730
-2,574
Cash and cash equivalents at beginning of period
72,769
72,769
68,039
-
Cash and cash equivalents at end of period
54,929
55,486
72,769
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net income
$24,024K
Depreciation and
amortization
$12,448K
Deferred income taxes
$3,659K
Foreign currency
losses, net
-$2,335K
Other assets
-$579K
Amortization of debt issuance
costs
$572K
Stock-based compensation
expense
$411K
Accrued expenses and
other liabilities
$361K
Net cash provided by
operating activities
$16,206K
Effect of exchange rate
changes on cash
$2,343K
Canceled cashflow
$28,183K
Net decrease in cash
and cash...
-$557K
Canceled cashflow
$18,549K
Maturities of short-term
investments
$9,500K
Other, net
-$2,010K
Revolving credit facility
borrowings
$73,000K
Inventories, net
$19,328K
Accounts receivable, net
$4,776K
Accounts payable
-$2,942K
Other current assets
$603K
Other
$534K
Net cash used by
investing activities
-$16,806K
Canceled cashflow
$11,510K
Net cash (used)
provided by financing...
-$2,300K
Canceled cashflow
$73,000K
Capital expenditures
$15,316K
Purchases of short-term
investments
$13,000K
Revolving credit facility
repayments
$65,000K
Dividends paid
$4,868K
Payments of long-term
debt
$4,063K
Payments of insurance
premium financing and...
$1,369K
Buy us a coffee
PHIBRO ANIMAL HEALTH CORP (PAHC)
PHIBRO ANIMAL HEALTH CORP (PAHC)